List of insiders holdings for TG THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| WEISS MICHAEL S CEO | 2024-01-08 18:32:45 | 13,074,929 0 | 13,074,929 | Form 4 |
| ROSENWALD LINDSAY A MD 10% Owner | 2010-03-11 16:45:47 | 11,104,453 0 | 11,104,453 | Form 13G |
| Lipschutz Lester E 10% Owner | 2007-08-01 16:30:35 | 8,941,873 0 | 8,941,873 | Form 13G |
| Opus Point Partners LLC 10% Owner | 2012-08-28 17:30:29 | 7,159,394 0 | 7,159,394 | Form 13D |
| RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2021-02-10 16:49:20 | 6,361,123 0 | 6,361,123 | Form 13G |
| RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 2021-02-10 16:49:20 | 6,361,123 0 | 6,361,123 | Form 13G |
| GIMBERT JOAN PONS Director | 2007-02-05 09:37:41 | 4,075,816 0 | 4,075,816 | Form 13G |
| McGuinness Michael COO & CFO | 2010-03-10 18:15:12 | 3,734,000 0 | 3,734,000 | Form 4 |
| WEISER MICHAEL Former Director Director | 2010-03-10 18:19:21 | 2,865,018 0 | 2,865,018 | Form 4 |
| LFB Biotechnologies S.A.S.U. 10% Owner | 2018-07-11 09:04:06 | 2,614,855 0 | 2,614,855 | Form 13D |
| FIRESTONE LEONARD MC Director | 2004-02-02 18:06:26 | 2,368,120 0 | 2,368,120 | Form 4 |
| ABEL DOUGLAS Director | 2010-03-10 18:06:49 | 1,429,000 0 | 1,429,000 | Form 4 |
| MCINERNEY TIMOTHY Director | 2010-03-10 18:02:18 | 1,311,575 0 | 1,311,575 | Form 4 |
| TANEN DAVID M Director | 2005-04-05 17:06:27 | 719,917 0 | 719,917 | Form 4 |
| KAZAM JOSHOA A Director | 2005-04-05 16:35:29 | 653,025 0 | 653,025 | Form 4 |
| Power Sean A CFO | 2024-02-14 21:53:50 | 641,969 0 | 641,969 | Form 5 |
| HARRIS ALAN G Chief Medical Officer | 2007-04-27 09:01:50 | 600,000 0 | 600,000 | Form 4 |
| ROSSETTOS NICHOLAS J Chief Financial Officer | 2005-08-19 16:40:24 | 567,030 0 | 567,030 | Form 4 |
| Steinhart Richard I Director | 2010-03-10 18:27:04 | 521,643 0 | 521,643 | Form 4 |
| Hoenlein Malcolm Former Director Director | 2010-03-10 18:10:59 | 467,201 0 | 467,201 | Form 4 |
| Hoberman Kenneth Director | 2024-06-20 18:05:55 | 264,935 0 | 264,935 | Form 4 |
| HUME DANIEL Director | 2024-06-20 18:07:09 | 240,489 0 | 240,489 | Form 4 |
| Echelard Yann Director | 2024-11-07 16:35:48 | 224,098 0 | 224,098 | Form 4 |
| MORVILLE MALCOLM Director | 2010-03-22 12:30:06 | 211,568 0 | 211,568 | Form 3 |
| Charney Laurence N Director | 2024-11-12 17:01:39 | 207,479 0 | 207,479 | Form 4 |
| SCHOENEBAUM MARK Director | 2018-06-28 17:00:26 | 125,949 0 | 125,949 | Form 4 |
| LOBELL J JAY See Footnote 1 | 2004-12-17 17:22:45 | 113,764 0 | 113,764 | Form 13G |
| KENNEDY WILLIAM JAMES Director | 2020-06-24 19:48:53 | 109,633 0 | 109,633 | Form 4 |
| Lonial Sagar Director | 2024-11-12 17:02:38 | 100,195 0 | 100,195 | Form 4 |
| Shimko David Director | 2010-03-22 12:34:29 | 92,313 0 | 92,313 | Form 4 |
| Herskowitz Neil Director | 2014-06-10 06:08:58 | 80,088 0 | 80,088 | Form 4 |
| Nordic Biotech Venture Fund II K/S 10% Owner | 2011-01-24 15:45:55 | 0 0 | 0 | Form 13D |